mifepristone has been researched along with onapristone in 117 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (5.98) | 18.7374 |
1990's | 80 (68.38) | 18.2507 |
2000's | 21 (17.95) | 29.6817 |
2010's | 9 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bender, SL; Crombie, D; Farmer, LJ; Goldman, ME; Hamann, LG; Johnson, MG; Jones, TK; Mais, DE; Wang, MW | 1 |
Crombie, DL; Edwards, JP; Goldman, ME; Jones, TK; Marschke, KB; Pooley, CL; Wang, MW | 1 |
Edwards, JP; Jones, TK; Mais, DE; Marschke, KB; Motamedi, M; Pio, B; Ringgenberg, JD; Schrader, WT; Tegley, CM; West, SJ; Zhi, L | 1 |
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Peplow, PV | 2 |
Gehring, S; Kühnel, W; Michna, H; Nishino, Y; Schneider, MR | 1 |
Blennerhassett, MG; Garfield, RE; Sakai, N | 1 |
Chwalisz, K; Elger, W; Fahrenholz, F; Garfield, R; Hackenberg, M | 1 |
el Etreby, MF; Louton, T; Michna, H; Nishino, Y; Schneider, MR | 1 |
Bhakta, A; Moudgil, VK; Nakao, M; Nath, R | 1 |
Muskiet, FA; Slappendel, EJ; van der Schoot, P; Zeegers, TA | 1 |
Healy, DL | 1 |
Cato, AC; Henderson, D; Klein-Hitpass, L; Ryffel, GU | 1 |
Uilenbroek, JT | 1 |
Bigsby, RM; Everett, LM | 1 |
el Etreby, MF; McGuire, WL; Michna, H; Nishino, Y; Schneider, M | 1 |
Slappendel, EJ; Uilenbroek, JT; van der Schoot, P | 2 |
Emons, G; Hansemann, K; Knuppen, R; Ortmann, O | 1 |
el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR | 4 |
Brooks, J; Holland, P; Kelly, R | 1 |
Neef, G; Wiechert, R | 1 |
Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Qing, SS | 1 |
Elger, WG; Pongubala, JM; Puri, CP | 1 |
Chwalisz, K; Elger, W; Osawa, Y; Shimizu, Y; Yarborough, CP | 1 |
de Gooyer, ME; Deckers, GH; Dijkema, R; Kloosterboer, HJ; Orlemans, EO; Schoonen, WG | 1 |
Chwalisz, K; Einspanier, A; Fritzemeier, KH; Fuhrmann, U; Garfield, RE; Stöckemann, K | 1 |
Altmann, M; Beck, CA; DeMarzo, A; Edwards, DP; Weigel, NL; Zhang, Y | 1 |
Danielsen, M; Zhang, S | 1 |
Archer, TK; Mymryk, JS | 2 |
Croxatto, HB; Fuentealba, B; Salvatierra, AM | 1 |
Allen, JM; Blaustein, JD; Clark, JH; Law, SW; Mani, SK; O'Malley, BW | 1 |
Alkhalaf, M; Coutts, A; Dotzlaw, H; Haddad-Alkhalaf, B; Murphy, LC | 1 |
Deckers, GH; Kloosterboer, HJ; Schoonen, WG | 1 |
Catt, KJ; Emons, G; Ortmann, O; Schulz, KD | 1 |
Bartsch, J; Beato, M; Truss, M | 1 |
Groshong, SD; Horwitz, KB; Miller, LA; Powell, RL; Sartorius, CA; Takimoto, GS; Tung, L | 1 |
Cato, AC; Gast, A; Heck, S; Herrlich, P; Kullmann, M; Ponta, H; Rahmsdorf, HJ | 1 |
Kawamoto, K; Kiya, K; Kurisu, K; Matsuda, Y; Sugiyama, K; Uozumi, T | 1 |
Hoeffler, JP; Horwitz, KB; Mohamed, MK; Takimoto, GS; Tung, L | 1 |
Goldman, ME; McDonnell, DP; Shahbaz, MM; Vegeto, E | 1 |
Delabre, K; Guiochon-Mantel, A; Lescop, P; Milgrom, E; Perrot-Applanat, M | 1 |
Horwitz, KB; Sartorius, CA; Takimoto, GS; Tung, L | 1 |
Lynch, M; Martin, JH; van den Berg, HW | 1 |
Kühnel, W; Michna, H; Rumpel, E | 1 |
Benhamou, B; Bocquel, MT; Chambon, P; Gronemeyer, H; Ji, J; Vergezac, A; Ylikomi, T | 1 |
Delabre, K; Guiochon-Mantel, A; Milgrom, E | 1 |
Hinko, A; Jeng, YJ; Soloff, MS | 1 |
Beck, CA; Edwards, DP; Weigel, NL; Zhang, Y | 1 |
Crombie, DL; Hayes, JS; Heap, RB; Parandoosh, Z; Tetzke, TA; Wang, MW | 1 |
Delabre, K; Guiochon-Mantel, A; Lescop, P; Milgrom, E | 1 |
Bender, SL; Farmer, LJ; Goldman, ME; Hamann, LG; Ianiro, T; Johnson, MG; Jones, TK; Mais, DE; Pathirana, C; Stein, RB | 1 |
Baulieu, EE; Breckwoldt, M; Chwalisz, K; Hodgen, GD; Neulen, J; Williams, RF | 1 |
Beck, S; Hackenberg, R; Hannig, K; Schmidt-Rhode, P; Scholz, A; Schulz, KD | 1 |
Casulari, LA; Maggi, R; Martini, L; Pimpinelli, F; Piva, F | 1 |
Fritzemeier, KH; Michna, H; Nishino, Y; Parczyk, K; Schneider, MR | 1 |
Baker, C; Hawkins, P; Norris, B; Quinn, PG; Sheridan, PL; Wei, LL | 1 |
Auger, AP; Blaustein, JD; Moffatt, CA | 1 |
Bardin, CW; Dao, B; Koide, SS; Li, XJ; Vanage, G | 1 |
Koper, JW; Lamberts, SW; Molijn, GJ; Stigter, E; van Uffelen, CJ | 1 |
Van Look, PF; von Hertzen, H | 1 |
Kilen, SM; Knox, KL; Ringstrom, SJ; Saberi, S; Schwartz, NB; Szabo, M | 1 |
Baird, DT; Buckley, CH; Cameron, ST; Critchley, HO; Kelly, RW | 1 |
Bygdeman, M; Danielsson, KG; Swahn, ML | 1 |
Gurpide, E; Markiewicz, L | 1 |
Delaunay, F; Gustafsson, J; Liden, J; Okret, S; Rafter, I | 1 |
Grimison, B; Groshong, SD; Horwitz, KB; Langan, TA; Lange, CA; Owen, GI; Schauer, IE; Sclafani, RA; Todd, MC | 1 |
Einspanier, A; Ivell, R; Kascheike, B; Lioutas, C; Walther, N | 1 |
Dinda, S; Herman, M; Hurd, C; Iwasaki, K; Kloosterboer, HJ; Moudgil, VK; Underwood, B | 1 |
Rao, AJ; Shanker, YG | 1 |
Edwards, DP; Gass, EK; Leonhardt, SA; Nordeen, SK | 1 |
Benet, LZ; Jang, GR | 2 |
Brouwer, A; Kuil, CW; van der Burg, B; van der Saag, PT | 1 |
Kilen, SM; Ringstrom, SJ; Saberi, S; Schwartz, NB; Szabo, M | 1 |
Borras, M; Lacroix, M; Leclercq, G; Legros, N | 1 |
El Etreby, MF; Liang, Y | 1 |
Calder, AA; Critchley, HO; Elliott, CL; Kelly, RW; Riley, SC | 1 |
Bellido, C; Gaytán, F; Morales, C; Sánchez-Criado, JE | 1 |
Schubert, AK | 1 |
Gonzalez, D; Sánchez-Criado, JE; Tébar, M | 1 |
Charreau, E; Lamb, C; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, MF; Pazos, P; Vanzulli, S | 1 |
Alban, P; Dinda, S; Hurd, C; Khattree, N; Moudgil, VK; Nag, K | 1 |
Kilen, SM; Nho, SJ; Schwartz, NB; Szabo, M | 1 |
Davis, JS; Hendry III, WJ; Hendry, IR; Rueda, BR; Slayden, OD; Stormshak, F | 1 |
Aguilar, R; Bellido, C; Gonzalez, D; Sánchez-Criado, JE | 1 |
Bellido, C; de Jong, FH; Sánchez-Criado, JE; Tébar, M | 1 |
Chiappetta, C; Hyder, SM; Stancel, GM | 1 |
Hill, JW; Levine, JE; Urban, JH; Xu, M | 1 |
Chwalisz, K; Cleve, A; Fritzemeier, KH; Fuhrmann, U; Hess-Stumpp, H; Hoffmann, J; Neef, G; Schwede, W | 1 |
Husted, RF; Itani, OA; Loftus, RW; Mick, VE; Schmidt, TJ; Thomas, CP | 1 |
Atkin, SL; Bilko, D; Newton, CJ; Pappa, S | 1 |
Alban, P; Dinda, S; Hurd, C; Khattree, N; Moudgil, VK | 1 |
Aw, SE; Lin, VC; Ng, EH; Tan, MG | 1 |
Auboeuf, D; Chen, JD; Liu, Z; O'Malley, BW; Tsai, MJ; Tsai, SY; Wong, J | 1 |
Chegini, N; Ma, C; Tang, XM; Williams, RS | 1 |
Cidlowski, JA; Schaaf, MJ | 1 |
Engström, C; Jaeger, R; Sager, G; Ørbo, A | 1 |
Hirsová, D; Kadlecová, L; Kolínská, J; Kraml, J; Nosková, L; Sinkora, J; Zákostelecká, M | 1 |
Curry, TE; Jo, M | 1 |
Edwards, DP; Elbi, C; Fletcher, TM; Hager, GL; Rayasam, GV; Walker, DA; Wolford, R | 1 |
Allan, GF; Clancy, J; Lai, MT; Musto, A; Palmer, E; Palmer, S | 1 |
Edwards, DP; Narayanan, R; Wardell, SE; Weigel, NL | 1 |
Chang, CY; Edwards, DP; Kazmin, D; Kimbrel, EA; Kobayashi, S; McDonnell, DP; Stice, JP; Wittmann, BM | 1 |
Sarkar, NN | 1 |
Amazit, L; Bellance, C; Guiochon-Mantel, A; Khan, JA; Lombès, M; Loosfelt, H | 1 |
Guil-Luna, S; Hellmén, E; Martín de las Mulas, J; Millán, Y; Sánchez-Céspedes, R | 1 |
Hayashi, N; Hirata, R; Hojo, T; Okuda, K; Sano, M | 1 |
Kotwica, J; Kowalik, MK; Rekawiecki, R | 1 |
Bolt, MJ; Edwards, DP; Grimm, SL; Mancini, MA; Treviño, LS; Weigel, NL | 1 |
Cooperrider, J; Custer, M; Dobyns, AE; Elsissy, JG; Heuerman, AC; Kirby, MA; Strilaeff, R; Stutz, KN; Yellon, SM | 1 |
12 review(s) available for mifepristone and onapristone
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Progesterone receptor antagonists and prostaglandins in human fertility regulation: a clinical review.
Topics: Abortifacient Agents, Steroidal; Animals; Estrenes; Female; Gonanes; Humans; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progesterone; Prostaglandins; Receptors, Progesterone | 1990 |
Antitumor activity and mechanism of action of different antiprogestins in experimental breast cancer models.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Gonanes; Kinetics; Mammary Neoplasms, Experimental; Mifepristone; Progesterone | 1990 |
Synthesis of antiprogestational steroids.
Topics: Chemical Phenomena; Chemistry; Estrenes; Gonanes; Mifepristone; Progestins | 1987 |
Mechanism of action of antiprogestins in the pregnant uterus.
Topics: Animals; Embryo Implantation; Female; Gonanes; Humans; In Vitro Techniques; Labor, Obstetric; Mifepristone; Models, Biological; Pregnancy; Primates; Progestins; Prostaglandins; Uterus | 1995 |
[Anti-progestins and contraception].
Topics: Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Embryo Implantation; Endometrium; Estrenes; Female; Glucocorticoids; Gonanes; Humans; Luteinizing Hormone; Mifepristone; Ovary; Ovulation; Progestins; Receptors, Progesterone | 1994 |
Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins.
Topics: Breast Neoplasms; Cell Division; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Genes, myc; Gonanes; Humans; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Proteins; Progestins; Transforming Growth Factors; Tumor Cells, Cultured | 1994 |
The Ernst Schering Poster Award. Intracellular traffic of steroid hormone receptors.
Topics: Amino Acid Sequence; Animals; beta-Galactosidase; Biological Transport; Cell Line; Cell Nucleus; Cricetinae; Cytoplasm; Gene Expression Regulation; Gonanes; Hormone Antagonists; Humans; Mice; Mifepristone; Molecular Sequence Data; Nuclear Envelope; Protein Sorting Signals; Receptors, Progesterone; Receptors, Steroid; Recombinant Fusion Proteins; Signal Transduction; Zinc Fingers | 1996 |
Discovery of novel intracellular receptor modulating drugs.
Topics: Animals; Anisoles; Chlorocebus aethiops; Chlorophyta; Cyclohexanes; Drug Design; Estrogen Replacement Therapy; Female; Gonanes; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Progesterone Congeners; Receptors, GABA; Receptors, Progesterone; Receptors, Steroid; Recombinant Proteins; Sleep Stages; Structure-Activity Relationship; Transfection | 1996 |
Antiprogestin-progesterone interactions.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Female; Gonanes; Hormone Antagonists; Humans; Mice; Mifepristone; Progesterone | 1996 |
Clinical uses of antiprogestogens.
Topics: Abortion, Induced; Antineoplastic Agents; Breast Neoplasms; Contraception; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Endometriosis; Estrenes; Female; Gonanes; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Progestins; Prostaglandins; Receptors, Progesterone | 1995 |
Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use.
Topics: Abortifacient Agents; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Contraceptives, Postcoital, Synthetic; Endometriosis; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Mifepristone; Progestins | 1997 |
105 other study(ies) available for mifepristone and onapristone
Article | Year |
---|---|
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.
Topics: Animals; Anisoles; Cell Line; Cyclohexanes; Cyclohexenes; Female; Humans; Magnetic Resonance Spectroscopy; Male; Mice; Receptors, Progesterone; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore.
Topics: Administration, Oral; Animals; Cell Line; Cercopithecus; Embryo Implantation; Female; Gonanes; Hormone Antagonists; Humans; Mice; Pregnancy; Quinolines; Receptors, Progesterone; Structure-Activity Relationship | 1998 |
Development of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore.
Topics: Animals; Cell Line; Chlorocebus aethiops; Humans; Inhibitory Concentration 50; Progesterone; Quinolines; Receptors, Progesterone; Receptors, Steroid; Structure-Activity Relationship; Transcription, Genetic; Transfection | 2003 |
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Prostaglandin E production by uteri of ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Female; Gonanes; In Vitro Techniques; Mifepristone; Ovariectomy; Pregnancy; Progesterone; Prostaglandins E; Rats; Uterus | 1992 |
The antitumor potency of progesterone antagonists is due to their differentiation potential.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Gonanes; Mammary Neoplasms, Experimental; Mice; Mifepristone; Progesterone; Rats | 1992 |
Effects of antiprogesterones on myometrial cell-to-cell coupling in pregnant guinea pigs.
Topics: Animals; Cell Communication; Electric Conductivity; Electrophysiology; Female; Fluorescent Dyes; Gonanes; Guinea Pigs; Hormone Antagonists; Isoquinolines; Microelectrodes; Mifepristone; Myometrium; Pregnancy; Progesterone; Time Factors | 1992 |
The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations.
Topics: Animals; Connexins; Dose-Response Relationship, Drug; Drug Synergism; Electrophysiology; Female; Gestational Age; Gonanes; Guinea Pigs; Intercellular Junctions; Labor, Induced; Membrane Proteins; Mifepristone; Myometrium; Oxytocin; Progesterone; Receptors, Angiotensin; Receptors, Oxytocin; Uterine Contraction | 1991 |
A bioassay for the evaluation of antiproliferative potencies of progesterone antagonists.
Topics: Animals; DNA; Female; Gonanes; Mammary Glands, Animal; Mifepristone; Organ Size; Progesterone; Rats; Rats, Inbred Strains; RNA | 1991 |
Uterine production of prostaglandins F2 alpha and 6-keto-F1 alpha by ovariectomized pregnant rats receiving antiprogesterone steroid or in which progesterone has been withdrawn.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dinoprost; Drug Implants; Epoprostenol; Estradiol; Female; Gonanes; Mifepristone; Organ Size; Ovariectomy; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Inbred Strains; Uterus | 1991 |
ZK98299, a novel antiprogesterone that does not interact with chicken oviduct progesterone receptor.
Topics: Animals; Antibodies, Monoclonal; Cattle; Chickens; Cytosol; Female; Gonanes; In Vitro Techniques; Mifepristone; Molecular Structure; Oviducts; Phosphorylation; Progesterone; Receptors, Progesterone; Uterus | 1991 |
Reduction of the intake of food and water is responsible for reduction of litter growth when dams are treated with a progesterone antagonist.
Topics: Animals; Animals, Newborn; Body Weight; Drinking; Eating; Female; Gonanes; Lactation; Male; Mifepristone; Milk; Ovariectomy; Pregnancy; Progesterone; Rats; Rats, Inbred Strains | 1991 |
Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.
Topics: Base Sequence; Binding, Competitive; DNA; Gonanes; Humans; Mifepristone; Molecular Sequence Data; Plasmids; Progesterone; Receptors, Progesterone; TATA Box; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured | 1991 |
Hormone concentrations and ovulatory response in rats treated with antiprogestagens.
Topics: Animals; Chorionic Gonadotropin; Female; Gonadotropins, Pituitary; Gonanes; Luteinizing Hormone; Mifepristone; Ovary; Ovulation; Progesterone; Prolactin; Rats; Rats, Inbred Strains | 1991 |
Effects of progestin antagonists, glucocorticoids and estrogen on progesterone-induced protein secreted by rabbit endometrial stromal cells in culture.
Topics: Animals; Cells, Cultured; Endometrium; Estrenes; Estrogens; Extracellular Matrix Proteins; Female; Glucocorticoids; Gonanes; Mifepristone; Progesterone; Progestins; Proteins; Rabbits | 1991 |
Progesterone antagonists block the growth of experimental mammary tumors in G0/G1.
Topics: Animals; Antineoplastic Agents; Cell Division; Female; G1 Phase; Gonanes; Mammary Neoplasms, Experimental; Mifepristone; Progesterone; Rats; Rats, Inbred Strains; Resting Phase, Cell Cycle | 1990 |
Effect of the progesterone antagonist mifepristone on the hypothalamo-hypophysial-ovarian axis in rats.
Topics: 20-alpha-Dihydroprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Bromocriptine; Delayed-Action Preparations; Female; Gonanes; Hypothalamo-Hypophyseal System; Mifepristone; Organ Size; Ovary; Pituitary Gland; Progesterone; Prolactin; Rats; Uterus | 1990 |
Modulatory actions of the new antiprogestins ZK 98.299 and ZK 98.734 and of RU 486 on luteinizing hormone secretion and progesterone effects in pituitary gonadotrophs.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Estradiol; Estrenes; Female; Gonanes; Kinetics; Luteinizing Hormone; Mifepristone; Pituitary Gland, Anterior; Progesterone; Progestins; Rats; Rats, Inbred Strains | 1990 |
Comparison of antiprogestin stimulation of uterine prostaglandin synthesis in vitro.
Topics: Animals; Female; Fertility Agents, Female; Gonanes; Guinea Pigs; In Vitro Techniques; Male; Mifepristone; Perfusion; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Uterus | 1990 |
Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Estrenes; Female; Gonanes; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mifepristone; Neoplasms, Hormone-Dependent; Progesterone; Rats; Rats, Inbred Strains | 1989 |
Failure of two progesterone antagonists, mifepristone and onapristone, to affect luteal activity in lactating rats.
Topics: Algestone; Animals; Corpus Luteum; Female; Gonanes; Lactation; Luteolysis; Mifepristone; Ovulation; Pregnancy; Progesterone; Prolactin; Rats; Rats, Inbred Strains | 1989 |
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Gonanes; Mammary Neoplasms, Experimental; Methylnitrosourea; Mifepristone; Neoplasm Transplantation; Organ Size; Ovariectomy; Ovary; Rats; Rats, Inbred Strains; Uterus; Vagina | 1989 |
The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Estradiol; Female; Gonanes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mifepristone; Ovariectomy; Progesterone; Tumor Cells, Cultured | 1989 |
Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
Topics: Abortion, Induced; Animals; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Gonanes; Guinea Pigs; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Prostaglandins E, Synthetic; Prostaglandins F; Uterine Contraction | 1987 |
Induction of menstruation by antiprogesterone ZK 98.299 in cycling bonnet monkeys.
Topics: Animals; Corpus Luteum; Estradiol; Estrenes; Female; Gonanes; Macaca radiata; Menstrual Cycle; Mifepristone; Progesterone | 1987 |
Inhibition of aromatase activity in human placental microsomes by 13-retro-antiprogestins.
Topics: Aromatase Inhibitors; Estrenes; Estrone; Female; Gonanes; Humans; Microsomes; Mifepristone; Placenta; Pregnancy; Progestins | 1995 |
Pharmacological properties of a new selective antiprogestagen: Org 33628.
Topics: Adrenal Glands; Animals; Cell Line; Estrenes; Female; Furans; Gonanes; Guinea Pigs; Humans; In Vitro Techniques; Mifepristone; Ovulation; Pregnancy; Progestins; Receptors, Cell Surface; Receptors, Progesterone; Structure-Activity Relationship | 1995 |
Progesterone receptor and the mechanism of action of progesterone antagonists.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; DNA-Binding Proteins; Estrenes; Gonanes; Humans; In Vitro Techniques; Mifepristone; Progesterone; Promegestone; Protein Binding; Protein Conformation; Receptors, Progesterone; Signal Transduction; Transcription Factors; Transcription, Genetic | 1995 |
8-Br-cAMP does not convert antagonists of the glucocorticoid receptor into agonists.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Line; CHO Cells; Cricetinae; Gonanes; Mice; Mifepristone; Progesterone; Promegestone; Receptors, Glucocorticoid; Transfection | 1995 |
Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo.
Topics: Animals; Breast Neoplasms; Cell Line, Transformed; Cell Transformation, Viral; Chromatin; Female; Gonanes; Humans; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Promoter Regions, Genetic; Receptors, Progesterone; Signal Transduction; Transcriptional Activation | 1995 |
Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor.
Topics: Animals; Base Sequence; DNA; Dose-Response Relationship, Drug; Female; Gonanes; Hypothalamus; Mifepristone; Molecular Sequence Data; Oligonucleotides, Antisense; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Sexual Behavior, Animal | 1994 |
Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Abortifacient Agents, Steroidal; Abortion, Induced; Androgen Antagonists; Animals; Estrenes; Female; Furans; Gonanes; Macaca; Male; Mammary Neoplasms, Experimental; Menstruation-Inducing Agents; Mifepristone; Pregnancy; Progestins; Rats; Receptors, Glucocorticoid; Receptors, Progesterone | 1994 |
Modulatory action of progesterone and progesterone antagonists on hypothalamic-pituitary function.
Topics: Animals; Cells, Cultured; Estrenes; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonanes; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Mifepristone; Ovariectomy; Pituitary Gland, Anterior; Progesterone; Rats; Rats, Sprague-Dawley; Rats, Wistar | 1994 |
Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo.
Topics: Base Sequence; Cell Line; DNA-Binding Proteins; Gene Expression Regulation; Gonanes; Humans; In Vitro Techniques; Mammary Tumor Virus, Mouse; Mifepristone; Molecular Sequence Data; Oligodeoxyribonucleotides; Progestins; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; RNA, Messenger; Transcription, Genetic | 1994 |
New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Topics: Base Sequence; Breast Neoplasms; Cyclic AMP; Female; Gonanes; Humans; Mifepristone; Molecular Sequence Data; Progestins; Receptors, Progesterone; Transcription, Genetic; Tumor Cells, Cultured | 1994 |
A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Cells, Cultured; DNA; DNA Mutational Analysis; Gene Expression Regulation; Glucocorticoids; Gonanes; Mifepristone; Molecular Sequence Data; Point Mutation; Promoter Regions, Genetic; Protein Conformation; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid; Structure-Activity Relationship | 1994 |
Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Female; Gonanes; Humans; Male; Meningeal Neoplasms; Meningioma; Mice; Mice, Nude; Middle Aged; Mifepristone; Progesterone; Receptors, Progesterone; Tumor Cells, Cultured | 1994 |
Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Topics: Binding Sites; DNA; Genes, fos; Genes, jun; Genes, Reporter; Gonanes; HeLa Cells; Humans; Leucine Zippers; Mifepristone; Phenotype; Progesterone; Promoter Regions, Genetic; Receptors, Progesterone; Recombinant Fusion Proteins; Transcription, Genetic; Transfection | 1993 |
The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity.
Topics: Animals; Cells, Cultured; Gonanes; Haplorhini; Humans; Mifepristone; Mineralocorticoid Receptor Antagonists; Molecular Conformation; Progestins; Receptors, Mineralocorticoid; Receptors, Progesterone; Repressor Proteins; Transcription, Genetic | 1994 |
Cytoplasmic-nuclear trafficking of progesterone receptor. In vivo study of the mechanism of action of antiprogestins.
Topics: Animals; Cell Nucleus; Cytoplasm; Gonanes; Mifepristone; Nuclear Localization Signals; Nuclear Proteins; Progestins; Protein Sorting Signals; Rabbits; Receptors, Progesterone | 1994 |
Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Base Sequence; beta-Galactosidase; Breast Neoplasms; Cell Line; Chloramphenicol O-Acetyltransferase; Cyclic AMP; DNA-Binding Proteins; Female; Gonanes; Humans; Mifepristone; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Phosphates; Progesterone; Promegestone; Receptors, Progesterone; Recombinant Proteins; Transcription Factors; Transfection; Tumor Cells, Cultured | 1993 |
The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.
Topics: Binding, Competitive; Breast Neoplasms; Dexamethasone; Down-Regulation; Female; Gonanes; Humans; Medroxyprogesterone Acetate; Mifepristone; Mitosis; Pregnenediones; Progesterone Congeners; Progestins; Receptors, Glucocorticoid; Receptors, Progesterone; Tumor Cells, Cultured | 1993 |
Morphology of the rat uterus after long-term treatment with progesterone antagonists.
Topics: Animals; Cytoplasmic Granules; Endometrium; Epithelial Cells; Epithelium; Female; Gonanes; Microscopy, Electron; Mifepristone; Progesterone; Rats; Rats, Sprague-Dawley; Uterus | 1993 |
Type II antagonists impair the DNA binding of steroid hormone receptors without affecting dimerization.
Topics: Animals; Binding, Competitive; DNA; Furans; Gene Expression; Gonanes; HeLa Cells; Humans; Mice; Mifepristone; Phosphorylation; Progesterone; Receptors, Glucocorticoid; Receptors, Progesterone; Transfection | 1993 |
In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA.
Topics: Animals; Cell Line; Chlorocebus aethiops; DNA-Binding Proteins; Gene Expression Regulation; Gonanes; In Vitro Techniques; Mifepristone; Protein Binding; Rabbits; Receptors, Progesterone; Recombinant Proteins; RNA, Messenger; Transcription, Genetic | 1993 |
Effectors of cyclic adenosine 5'-monophosphate up-regulating-oxytocin receptors in rabbit amnion cells: isoproterenol, parathyroid hormone-related protein, and potentiation by cortisol.
Topics: Adenylyl Cyclases; Amnion; Animals; Colforsin; Cyclic AMP; DNA; Drug Synergism; Female; Gonanes; Hormone Antagonists; Hydrocortisone; Isoproterenol; Mifepristone; Parathyroid Hormone-Related Protein; Pregnancy; Proteins; Rabbits; Receptors, Glucocorticoid; Receptors, Oxytocin | 1995 |
Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor.
Topics: Amino Acid Sequence; Breast Neoplasms; Female; Gonanes; Humans; Mifepristone; Molecular Sequence Data; Phosphorylation; Progestins; Receptors, Progesterone; Signal Transduction; Tumor Cells, Cultured | 1996 |
Progesterone and oestrogen receptors in the decidualized mouse uterus and effects of different types of anti-progesterone treatment.
Topics: Animals; Antibodies, Monoclonal; Decidua; Female; Gonanes; Mice; Mice, Inbred Strains; Mifepristone; Progesterone; Pseudopregnancy; Receptors, Estrogen; Receptors, Progesterone | 1995 |
Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Topics: Animals; Binding, Competitive; Chromatin; Dexamethasone; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Promoter Regions, Genetic; Receptors, Glucocorticoid; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Topics: Animals; Cell Division; Endometrium; Estrogen Antagonists; Female; Gonanes; Hormone Antagonists; Macaca fascicularis; Mifepristone; Progesterone; Receptors, Estrogen; Receptors, Progesterone | 1996 |
Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells.
Topics: Androgen Antagonists; Antineoplastic Agents; Binding, Competitive; Breast Neoplasms; Cell Division; Dihydrotestosterone; Estrenes; Flutamide; Gonanes; Humans; Mifepristone; Models, Biological; Progestins; Receptors, Androgen; Transfection; Tumor Cells, Cultured | 1996 |
Antiprogestins inhibit the binding of opioids to mu-opioid receptors in nervous membrane preparations.
Topics: Analgesics; Animals; Dihydromorphine; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Gonanes; Hormone Antagonists; Humans; In Vitro Techniques; Male; Membranes; Mice; Mifepristone; Narcotic Antagonists; Narcotics; Nerve Tissue; Nervous System Neoplasms; Neuroblastoma; Progestins; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Sodium; Tumor Cells, Cultured | 1996 |
An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Topics: Antineoplastic Agents; Breast Neoplasms; Enhancer Elements, Genetic; Gonanes; HeLa Cells; Hormone Antagonists; Humans; Methionine; Mifepristone; Progesterone Congeners; Progestins; Promegestone; Protein Biosynthesis; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1996 |
Progesterone-independent activation of rat brain progestin receptors by reproductive stimuli.
Topics: Animals; Female; Genes, fos; Gonanes; Mifepristone; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; Sexual Behavior, Animal | 1997 |
Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
Topics: Abortion, Induced; Administration, Oral; Animals; Cohort Studies; Contraceptives, Postcoital; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Estradiol; Estrenes; Female; Furans; Gonanes; Hormone Antagonists; Male; Mifepristone; Norandrostanes; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley | 1997 |
Antiprogestins and iatrogenic glucocorticoid resistance.
Topics: Binding, Competitive; Dexamethasone; Drug Resistance; Estrenes; Furans; Glucocorticoids; Gonanes; Hormone Antagonists; Humans; Hydrocortisone; In Vitro Techniques; Lymphocyte Activation; Meningeal Neoplasms; Meningioma; Mifepristone; Progestins; Receptors, Glucocorticoid | 1997 |
The antiprogestins RU486 and ZK98299 affect follicle-stimulating hormone secretion differentially on estrus, but not on proestrus.
Topics: Animals; Estrus; Female; Follicle Stimulating Hormone; Follicle Stimulating Hormone, beta Subunit; Gonanes; Hormone Antagonists; Luteinizing Hormone; Mifepristone; Pituitary Gland, Anterior; Proestrus; Progestins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription, Genetic; Uterus | 1997 |
Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Topics: Abortifacient Agents, Steroidal; Biomarkers; Biopsy; Cell Division; Embryo Implantation; Endometrium; Female; Fertility Agents, Female; Glycodelin; Glycoproteins; Gonanes; Growth Inhibitors; Hormone Antagonists; Humans; Hydroxyprostaglandin Dehydrogenases; Interleukin-6; Ki-67 Antigen; Leukemia Inhibitory Factor; Luteinizing Hormone; Lymphokines; Menstrual Cycle; Mifepristone; Pregnancy Proteins | 1997 |
The possible use of antiprogestins for contraception.
Topics: Contraceptives, Oral, Synthetic; Endometrium; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnancy; Progesterone | 1997 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation.
Topics: Amino Acid Sequence; Animals; Arginine; COS Cells; Dexamethasone; Dimerization; Glucocorticoids; Gonanes; Lysine; Mifepristone; Molecular Sequence Data; NF-kappa B; Rats; Receptors, Glucocorticoid; Receptors, Thyroid Hormone; Recombinant Fusion Proteins; Repressor Proteins; Structure-Activity Relationship; Transcription Factor RelA; Transcriptional Activation; Zinc Fingers | 1997 |
Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
Topics: Breast Neoplasms; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin A; Cyclin B; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; G1 Phase; Gene Expression Regulation; Gonanes; Hormone Antagonists; Humans; Microtubule-Associated Proteins; Mifepristone; Progesterone; Promegestone; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1997 |
An autocrine progesterone positive feedback loop mediates oxytocin upregulation in bovine granulosa cells during luteinization.
Topics: Animals; Blotting, Northern; Cattle; Corpus Luteum; Dexamethasone; Feedback; Female; Glucocorticoids; Gonanes; Granulosa Cells; Hormone Antagonists; Medroxyprogesterone Acetate; Mifepristone; Oxytocin; Progesterone; Progestins; RNA, Messenger | 1997 |
Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
Topics: Binding, Competitive; Blotting, Western; DNA; Electrophoresis, Polyacrylamide Gel; Estrenes; Furans; Gonanes; Hormone Antagonists; Humans; Ligands; Mifepristone; Phosphorylation; Progesterone Congeners; Promegestone; Receptors, Progesterone; Sodium Dodecyl Sulfate; Tumor Cells, Cultured | 1997 |
Regulation of progesterone biosynthesis in the human placenta by estradiol 17 beta and progesterone.
Topics: Estradiol; Fadrozole; Female; Fulvestrant; Gonanes; Homeostasis; Hormone Antagonists; Humans; Mifepristone; Placenta; Pregnancy; Progesterone | 1997 |
The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Topics: Animals; Binding Sites; Binding, Competitive; COS Cells; DNA; Gonanes; Hormone Antagonists; Humans; Mice; Mifepristone; Progesterone; Promoter Regions, Genetic; Protein Conformation; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; TATA Box; Transfection | 1998 |
Antiprogestin-mediated inactivation of cytochrome P450 3A4.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; Gonanes; Hormone Antagonists; Humans; Microsomes, Liver; Midazolam; Mifepristone; Mixed Function Oxygenases; NADP; Spectrophotometry; Tissue Donors | 1998 |
Interference between progesterone and dioxin signal transduction pathways. Different mechanisms are involved in repression by the progesterone receptor A and B isoforms.
Topics: Breast Neoplasms; Cytochrome P-450 CYP1A1; Female; Gene Expression Regulation, Enzymologic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Polychlorinated Dibenzodioxins; Pregnenediones; Progesterone Congeners; Receptors, Aryl Hydrocarbon; Receptors, Progesterone; Recombinant Proteins; Signal Transduction; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Up-Regulation | 1998 |
Antiprogestins suppress basal and activin-stimulated follicle-stimulating hormone secretion in an estrogen-dependent manner.
Topics: Activins; Animals; Cells, Cultured; Estradiol; Female; Follicle Stimulating Hormone; Gonanes; Hormone Antagonists; Inhibins; Luteinizing Hormone; Metestrus; Mifepristone; Pituitary Gland, Anterior; Proestrus; Progestins; Rats; Rats, Sprague-Dawley | 1998 |
Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers.
Topics: Breast Neoplasms; Cell Division; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnenediones; Progestins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1997 |
Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Gonanes; Hormone Antagonists; Humans; Mice; Mice, Nude; Mifepristone; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured | 1998 |
Regulation of interleukin 8 production in the term human placenta during labor and by antigestagens.
Topics: Culture Techniques; Estrenes; Female; Gonanes; Hormone Antagonists; Humans; Immunohistochemistry; Interleukin-8; Labor, Obstetric; Mifepristone; Placenta; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Progestins | 1998 |
Both prolactin and progesterone in proestrus are necessary for the induction of apoptosis in the regressing corpus luteum of the rat.
Topics: Animals; Apoptosis; Bromocriptine; Corpus Luteum; Dopamine Agonists; Female; Gonanes; Hormone Antagonists; Luteolysis; Macrophages; Mifepristone; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar | 1998 |
[Effects of progesterone antagonists on the eosinophilic granulocytes in the rat uterus].
Topics: Animals; Endometrium; Eosinophils; Estrogens; Estrone; Female; Gonanes; Hormone Antagonists; Mifepristone; Myometrium; Ovariectomy; Progesterone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sexual Maturation; Uterus | 1998 |
Mechanism of the stimulatory action of antisteroid RU486 on follicle-stimulating hormone secretion in the cyclic Rat.
Topics: Animals; Estrenes; Estrus; Female; Follicle Stimulating Hormone; Furans; Gonadotropin-Releasing Hormone; Gonanes; Hormone Antagonists; Luteinizing Hormone; Mifepristone; Pentobarbital; Progesterone; Rats; Rats, Wistar | 1999 |
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Topics: Adenocarcinoma; Androgens; Animals; Binding Sites; Estradiol; Female; Flutamide; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasms, Hormone-Dependent; Oligonucleotides, Antisense; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured | 1999 |
Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
Topics: Blotting, Western; Breast Neoplasms; Cell Division; Charcoal; Culture Media; Electrophoresis, Polyacrylamide Gel; Estradiol; Female; Gonanes; Hormone Antagonists; Humans; Mifepristone; Phosphorylation; Progesterone Congeners; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured | 1999 |
Progesterone receptor A and B messenger ribonucleic acid levels in the anterior pituitary of rats are regulated by estrogen.
Topics: Animals; Estrogens; Estrus; Female; Gene Expression Regulation; Gonanes; Hormone Antagonists; Metestrus; Mifepristone; Ovariectomy; Pituitary Gland, Anterior; Proestrus; Progesterone; Rats; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2000 |
Decreased progesterone levels and progesterone receptor antagonists promote apoptotic cell death in bovine luteal cells.
Topics: Aminoglutethimide; Animals; Apoptosis; Cattle; Corpus Luteum; Cytochrome P-450 Enzyme Inhibitors; DNA, Complementary; Enzyme Inhibitors; Female; Gonanes; Hormone Antagonists; Immunohistochemistry; Mifepristone; Progesterone; Radioimmunoassay; Receptors, Progesterone; RNA, Messenger; Steroids | 2000 |
Antiprogestins RU486 and ZK299 suppress basal and LHRH-stimulated FSH and LH secretion at pituitary level in the rat in an oestrous cycle stage-dependent manner.
Topics: Analysis of Variance; Animals; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Gonanes; Hormone Antagonists; Luteinizing Hormone; Median Eminence; Mifepristone; Ovariectomy; Pituitary Gland; Proestrus; Rats; Rats, Wistar | 1999 |
Comparison of the effects of antiprogestins RU38486, ZK98299 and ORG31710 on periovulatory hypophysial, ovarian and adrenal hormone secretion in the rat.
Topics: Adrenal Glands; Animals; Corticosterone; Estrenes; Female; Follicle Stimulating Hormone; Furans; Gonanes; Hormone Antagonists; Inhibins; Luteinizing Hormone; Mifepristone; Ovary; Ovulation; Pituitary Gland, Posterior; Progesterone; Rats; Rats, Wistar | 2000 |
Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
Topics: Animals; Endothelial Growth Factors; Estradiol; Female; Fulvestrant; Gonanes; Hormone Antagonists; Lymphokines; Mifepristone; Progestins; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Uterus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Regulation of hypothalamic neuropeptide Y Y1 receptor gene expression during the estrous cycle: role of progesterone receptors.
Topics: Animals; Estrus; Exons; Female; Gonadal Steroid Hormones; Gonanes; Hormone Antagonists; Hypothalamus; Indicators and Reagents; Mice; Mice, Knockout; Mifepristone; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, Progesterone | 2000 |
Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist.
Topics: Abortifacient Agents; Adrenalectomy; Androgen Antagonists; Animals; Antineoplastic Agents; Binding, Competitive; Castration; Cell Line; Estrenes; Female; Glucocorticoids; Gonanes; Hormone Antagonists; Ligands; Male; Mammary Neoplasms, Experimental; Mifepristone; Progesterone; Protein Isoforms; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Transcriptional Activation | 2000 |
The alpha-subunit of the epithelial sodium channel is an aldosterone-induced transcript in mammalian collecting ducts, and this transcriptional response is mediated via distinct cis-elements in the 5'-flanking region of the gene.
Topics: Aldosterone; Animals; Base Sequence; Binding Sites; Cells, Cultured; Cloning, Molecular; Dactinomycin; Dexamethasone; Dogs; Epithelial Sodium Channels; Gonanes; Humans; Kidney Tubules, Collecting; Mice; Mifepristone; Molecular Sequence Data; Promoter Regions, Genetic; Protein Subunits; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Regulatory Sequences, Nucleic Acid; Response Elements; Sodium Channels; Transcription, Genetic | 2001 |
Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Topics: Adenosine Triphosphate; Cell Death; Dexamethasone; Estradiol; Estrogen Receptor Modulators; Estrone; Flow Cytometry; Flutamide; Fulvestrant; Glucocorticoids; Glyceraldehyde-3-Phosphate Dehydrogenases; Gonanes; Humans; Hydrogen Peroxide; Microscopy, Fluorescence; Mifepristone; Pituitary Neoplasms; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Cell Surface; Transfection; Tumor Cells, Cultured | 2001 |
Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor Modulators; Estrogens; Fulvestrant; Gonanes; Humans; Mifepristone; Phosphorylation; Progesterone; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Retinoblastoma Protein; Tumor Cells, Cultured | 2001 |
Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Cell Size; Enzyme Activation; Female; Focal Adhesions; Gonanes; Hormone Antagonists; Humans; MAP Kinase Signaling System; Mifepristone; Progesterone; Receptors, Progesterone; Recombinant Fusion Proteins; Stress Fibers; Transfection; Tumor Cells, Cultured | 2001 |
Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Topics: Gonanes; HeLa Cells; Hormone Antagonists; Humans; Ligands; Mifepristone; Mutagenesis, Site-Directed; Receptors, Progesterone; Recombinant Proteins; Repressor Proteins; Trans-Activators; Transcription, Genetic; Transfection | 2002 |
Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression.
Topics: Estradiol; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Gonanes; Humans; Leiomyoma; Leuprolide; Medroxyprogesterone Acetate; Mifepristone; Muscle Development; Myocytes, Smooth Muscle; Myometrium; Oligopeptides; Progestins; Steroids; Transforming Growth Factors | 2002 |
Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
Topics: Active Transport, Cell Nucleus; Animals; Bacterial Proteins; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Corticosterone; Cortodoxone; COS Cells; Cysteine Endopeptidases; Cytoplasm; Dexamethasone; Fluorescent Dyes; Genes, Reporter; Gonanes; HeLa Cells; Humans; Hydrocortisone; Kidney; Leupeptins; Ligands; Luminescent Proteins; Microscopy, Confocal; Mifepristone; Multienzyme Complexes; Mutagenesis, Site-Directed; Photochemistry; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Binding; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Sequence Deletion; Transfection; Triamcinolone Acetonide | 2003 |
Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Transformed; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Gonanes; Hormone Antagonists; Humans; Mifepristone; Progestins; Radioimmunoassay; Receptors, Steroid; Time Factors | 2003 |
Glucocorticoid agonistic and antagonistic effects of mifepristone and onapristone on thymocyte subset composition and CD26/dipeptidyl peptidase IV activity in infant male rats.
Topics: Animals; Animals, Newborn; CD4 Antigens; CD4-Positive T-Lymphocytes; CD8 Antigens; CD8-Positive T-Lymphocytes; Cell Count; Dipeptidyl Peptidase 4; Glucocorticoids; Gonanes; Hydrocortisone; Male; Mifepristone; Organ Size; Rats; Rats, Wistar; Thymus Gland | 2003 |
Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary.
Topics: Animals; Cells, Cultured; Cycloheximide; Cyclooxygenase Inhibitors; Female; Follicular Phase; Gene Expression Regulation; Gonanes; Granulosa Cells; Hormone Antagonists; Indomethacin; Luteal Phase; Luteinizing Hormone; Matrix Metalloproteinases, Secreted; Metalloendopeptidases; Mifepristone; Ovary; Ovulation; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Theca Cells; Tissue Distribution | 2004 |
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.
Topics: Cell Nucleus; Cells, Cultured; Chromatin; Chromatin Assembly and Disassembly; DNA Helicases; Fluorescence Recovery After Photobleaching; Gonanes; Green Fluorescent Proteins; Humans; Ligands; Mammary Tumor Virus, Mouse; Mifepristone; Nuclear Proteins; Promegestone; Promoter Regions, Genetic; Receptors, Progesterone; Transcription Factors | 2005 |
Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.
Topics: Animals; DNA; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Gonanes; Hormone Antagonists; Humans; In Vitro Techniques; Male; Mifepristone; Progestins; Protein Binding; Rabbits; Rats; Receptors, Progesterone; Steroids; Tumor Cells, Cultured | 2006 |
Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400.
Topics: Animals; Chlorocebus aethiops; COS Cells; Cyclin A; Cyclin-Dependent Kinase 2; Gonanes; HeLa Cells; Hormone Antagonists; Humans; Mifepristone; Nuclear Receptor Coactivator 1; Phosphorylation; Promegestone; Protein Interaction Domains and Motifs; Rats; Receptors, Progesterone; Repressor Proteins; Serine; Transcriptional Activation | 2010 |
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.
Topics: Amino Acid Sequence; Cell Line; Cell Line, Tumor; Enhancer Elements, Genetic; Epithelial Cells; Female; Gonanes; Humans; Inflammatory Breast Neoplasms; Interleukin-1beta; Mifepristone; Molecular Sequence Data; NF-kappa B; Progesterone; Progestins; Promoter Regions, Genetic; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Signal Transduction; Transcriptional Activation; Translocation, Genetic | 2010 |
The state-of-the-art of emergency contraception with the cutting edge drug.
Topics: Contraception, Postcoital; Contraceptive Agents, Female; Estrenes; Female; Gonanes; Humans; Mifepristone; Norpregnadienes; Oximes; Pregnancy; Receptors, Progesterone | 2011 |
p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Topics: Breast Neoplasms; Cell Line, Tumor; Endometrial Neoplasms; Female; Gonanes; Humans; Ligands; MAP Kinase Kinase Kinase 1; Mifepristone; Mitogen-Activated Protein Kinase 1; Models, Biological; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Phosphoserine; Promegestone; Proteasome Endopeptidase Complex; Protein Isoforms; Protein Stability; Receptors, Progesterone; Transcription, Genetic | 2011 |
The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dogs; Gonanes; Hormone Antagonists; Mammary Neoplasms, Animal; Mifepristone | 2014 |
Potential role of hCG in apoptosis of human luteinized granulosa cells.
Topics: Adult; Apoptosis; Caspase 3; Cell Survival; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Female; Fertilization in Vitro; Gonanes; Granulosa Cells; Humans; Immunoenzyme Techniques; Luteinizing Hormone; Luteolysis; Mifepristone; Progesterone | 2015 |
Onapristone (ZK299) and mifepristone (RU486) regulate the messenger RNA and protein expression levels of the progesterone receptor isoforms A and B in the bovine endometrium.
Topics: Animals; Cattle; Endometrium; Female; Gene Expression Regulation; Gonanes; Hormone Antagonists; Mifepristone; Progesterone; Prostaglandins; Receptors, Progesterone; RNA, Messenger | 2015 |
Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.
Topics: Chromones; Cyclin-Dependent Kinase 2; DNA-Activated Protein Kinase; Gonanes; HeLa Cells; Humans; Mediator Complex; Mifepristone; Models, Biological; Morpholines; Promegestone; Purines; Receptors, Progesterone; Recombinant Proteins; Transcription, Genetic | 2016 |
Progesterone Receptor-Mediated Actions Regulate Remodeling of the Cervix in Preparation for Preterm Parturition.
Topics: Animals; Cell Count; Cervical Ripening; Cervix Uteri; Female; Gonanes; Macrophages; Mice; Mifepristone; Neutrophils; Ovariectomy; Pregnancy; Premature Birth; Receptors, Progesterone | 2016 |